Enhanced antitumor efficacy of a vascular disrupting agent combined with an antiangiogenic in a rat liver tumor model evaluated by multiparametric MRI.
作者:
主题词
血管生成抑制剂(Angiogenesis Inhibitors);动物(Animals);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);趋化因子CXCL12(Chemokine CXCL12);内皮细胞(Endothelial Cells);人类(Humans);肝肿瘤(Liver Neoplasms);磁共振成像(Magnetic Resonance Imaging);微循环(Microcirculation);坏死(Necrosis);有机磷化合物(Organophosphorus Compounds);大鼠(Rats);干细胞(Stem Cells);沙立度胺(Thalidomide)
DOI
10.1371/journal.pone.0041140
PMID
22815943
发布时间
2021-10-21
- 浏览14
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文